Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204678 | SCV000261372 | benign | Hereditary spastic paraplegia 2 | 2023-03-23 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514040 | SCV000610952 | likely benign | not provided | 2017-09-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000514040 | SCV000843294 | benign | not provided | 2017-09-19 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV001258262 | SCV001435182 | benign | Pelizaeus-Merzbacher disease | criteria provided, single submitter | research | The hemizygous c.-31C>T variant in PLP1 has been identified in a Japanese individual with Perlizaeus-Merzbacher disease (PMID: 8723686), and has been identified in >2% of East Asian chromosomes, 61 hemizygotes, and 1 homozygote by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for X-linked recessive Perlizaeus-Merzbacher disease. | |
Fulgent Genetics, |
RCV002500653 | SCV002804941 | likely benign | Pelizaeus-Merzbacher disease; Hereditary spastic paraplegia 2 | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514040 | SCV003761863 | likely benign | not provided | 2021-10-13 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Breakthrough Genomics, |
RCV000514040 | SCV005206656 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV001815250 | SCV000032070 | uncertain significance | Pelizaeus-Merzbacher disease, mild | 1996-01-01 | no assertion criteria provided | literature only |